PMC:7402624 / 20455-20686 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T146","span":{"begin":67,"end":71},"obj":"Body_part"},{"id":"T147","span":{"begin":181,"end":186},"obj":"Body_part"}],"attributes":[{"id":"A146","pred":"fma_id","subj":"T146","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A147","pred":"fma_id","subj":"T147","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"However, whereas ~2/3 of patients had KI67+ non-naïve CD4 or CD8 T cell frequencies above controls, ~1/3 of the COVID-19 patients had no increase in frequency of KI67+ CD4 or CD8 T cells above that observed in HD (Fig. 3, D and F)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"697","span":{"begin":54,"end":57},"obj":"Gene"},{"id":"698","span":{"begin":61,"end":64},"obj":"Gene"},{"id":"699","span":{"begin":168,"end":171},"obj":"Gene"},{"id":"700","span":{"begin":175,"end":178},"obj":"Gene"},{"id":"717","span":{"begin":25,"end":33},"obj":"Species"},{"id":"718","span":{"begin":121,"end":129},"obj":"Species"},{"id":"736","span":{"begin":112,"end":120},"obj":"Disease"},{"id":"737","span":{"begin":210,"end":212},"obj":"Disease"}],"attributes":[{"id":"A697","pred":"tao:has_database_id","subj":"697","obj":"Gene:920"},{"id":"A698","pred":"tao:has_database_id","subj":"698","obj":"Gene:925"},{"id":"A699","pred":"tao:has_database_id","subj":"699","obj":"Gene:920"},{"id":"A700","pred":"tao:has_database_id","subj":"700","obj":"Gene:925"},{"id":"A717","pred":"tao:has_database_id","subj":"717","obj":"Tax:9606"},{"id":"A718","pred":"tao:has_database_id","subj":"718","obj":"Tax:9606"},{"id":"A736","pred":"tao:has_database_id","subj":"736","obj":"MESH:C000657245"},{"id":"A737","pred":"tao:has_database_id","subj":"737","obj":"MESH:D006816"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"However, whereas ~2/3 of patients had KI67+ non-naïve CD4 or CD8 T cell frequencies above controls, ~1/3 of the COVID-19 patients had no increase in frequency of KI67+ CD4 or CD8 T cells above that observed in HD (Fig. 3, D and F)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T150","span":{"begin":112,"end":120},"obj":"Disease"},{"id":"T151","span":{"begin":210,"end":212},"obj":"Disease"}],"attributes":[{"id":"A150","pred":"mondo_id","subj":"T150","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A151","pred":"mondo_id","subj":"T151","obj":"http://purl.obolibrary.org/obo/MONDO_0007739"}],"text":"However, whereas ~2/3 of patients had KI67+ non-naïve CD4 or CD8 T cell frequencies above controls, ~1/3 of the COVID-19 patients had no increase in frequency of KI67+ CD4 or CD8 T cells above that observed in HD (Fig. 3, D and F)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T352","span":{"begin":54,"end":57},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T353","span":{"begin":61,"end":64},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T354","span":{"begin":65,"end":71},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T355","span":{"begin":168,"end":171},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T356","span":{"begin":175,"end":178},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T357","span":{"begin":179,"end":186},"obj":"http://purl.obolibrary.org/obo/CL_0000084"}],"text":"However, whereas ~2/3 of patients had KI67+ non-naïve CD4 or CD8 T cell frequencies above controls, ~1/3 of the COVID-19 patients had no increase in frequency of KI67+ CD4 or CD8 T cells above that observed in HD (Fig. 3, D and F)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T112","span":{"begin":210,"end":212},"obj":"Chemical"}],"attributes":[{"id":"A112","pred":"chebi_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/CHEBI_73925"}],"text":"However, whereas ~2/3 of patients had KI67+ non-naïve CD4 or CD8 T cell frequencies above controls, ~1/3 of the COVID-19 patients had no increase in frequency of KI67+ CD4 or CD8 T cells above that observed in HD (Fig. 3, D and F)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T129","span":{"begin":0,"end":231},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"However, whereas ~2/3 of patients had KI67+ non-naïve CD4 or CD8 T cell frequencies above controls, ~1/3 of the COVID-19 patients had no increase in frequency of KI67+ CD4 or CD8 T cells above that observed in HD (Fig. 3, D and F)."}